Effect of Hyperinsulinemia and Type 2 Diabetes-Like Hyperglycemia on Expression of Hepatic Cytochrome P450 and Glutathione S-Transferase Isoforms in a New Zealand Obese-Derived Mouse Backcross Population
Open Access
- 1 August 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 302 (2) , 442-450
- https://doi.org/10.1124/jpet.102.033553
Abstract
The binding of [3H]methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (methoxymethyl-MTEP), a potent and selective antagonist for metabotropic glutamate (mGlu)5 receptors, was characterized in rat brain both in vitro and in vivo. Nonspecific binding, as defined with 10 μM 2-methyl-6-(phenylethynyl)-pyridine (MPEP), was less than 10% of total binding in rat brain membranes. The binding of [3H]methoxymethyl-MTEP was of high affinity (Kd = 20 ± 2.7 nM), saturable (Bmax = 487 ± 48 fmol/mg protein), and to a single site. The mGlu5 antagonists methoxymethyl-MTEP and MPEP displaced [3H]methoxymethyl-MTEP binding with IC50values of 30 and 15 nM, respectively. In vivo administration of [3H]methoxymethyl-MTEP (50 μCi/kg i.v.) revealed 12-fold higher binding in hippocampus (an area enriched in mGlu5 receptors) relative to cerebellum (an area with few mGlu5 receptors) in rats. Similarly, administration of [3H]methoxymethyl-MTEP to mGlu5-deficient mice demonstrated binding at background levels in forebrain, whereas wild-type littermates exhibited 17-fold higher binding in forebrain relative to cerebellum. Systemic administration of unlabeled mGlu5 antagonists methoxymethyl-MTEP and MPEP to rats reduced the binding of [3H]methoxymethyl-MTEP with ID50 values of 0.8 and 2 mg/kg i.p., respectively, 1 h post-treatment. The mGlu5 agonist 2-chloro-5-hydroxyphenylglycine (CHPG) (0.3, 1, and 3 μmol) dose-dependently increased phosphoinositide (PI) hydrolysis in the hippocampus after i.c.v. administration in rats. CHPG-evoked increases in PI hydrolysis were blocked with MPEP at a dose (10 mg/kg i.p.) that markedly reduced [3H]methoxymethyl-MTEP binding in vivo. These results indicate that [3H]methoxymethyl-MTEP is a selective radioligand for labeling mGlu5 and is useful for studying the binding of mGlu5 receptors in rat brain in vitro and in vivo.Keywords
This publication has 43 references indexed in Scilit:
- Hepatic Cytochrome P450 Regulation in Disease StatesCurrent Drug Metabolism, 2001
- Free Fatty Acids and Pathogenesis of Type 2 Diabetes MellitusTrends in Endocrinology & Metabolism, 2000
- STAT5b-deficient Mice Are Growth Hormone Pulse-resistantPublished by Elsevier ,1999
- Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.Diabetes, 1999
- Down-Regulation of Cytochrome P450 2C Family Members and Positive Acute-Phase Response Gene Expression by Peroxisome Proliferator ChemicalsMolecular Pharmacology, 1998
- Sex differences in the diabetes-induced modulation of rat hepatic cytochrome p450 proteinsBiochemical Pharmacology, 1993
- Cytochrome P450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetesBiochemical Pharmacology, 1992
- Growth Hormone-Dependent and -Independent Regulation of Cytochrome P-450 Isozyme Expression in Streptozotocin-Diabetic Rats*Endocrinology, 1991
- Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetesBiochemical Journal, 1990
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976